Omada Health, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Omada Health, Inc. (OMDA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings of $1.47 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-06.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings · last filed 2026-03-06
- Omada Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Omada Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-09-30 was $212.00K.
- Omada Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-06-30 was $736.00K.
- Omada Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for the quarter ending 2025-03-31 was $520.00K, a 38.67% increase year-over-year.
- Omada Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2025 was $1.47M.
- Omada Health, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, gain (loss) included in earnings for fiscal 2024 was -$218.00K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $212.00K derived: sum of 2 quarters · filed 2026-03-06 | $948.00K derived: sum of 3 quarters · filed 2026-03-06 | $1.47M 10-K · filed 2026-03-06 |
| 2025-09-30 | $212.00K derived: 10-K 12 month − 3 quarters · filed 2026-03-06 | $948.00K derived: sum of 2 quarters · filed 2026-03-06 | $1.47M 10-Q · filed 2025-11-07 | $1.70M derived: sum of 4 quarters · filed 2026-03-06 |
| 2025-06-30 | $736.00K 10-Q · filed 2025-08-08 | $1.26M derived: sum of 2 quarters · filed 2025-08-08 | $1.48M derived: sum of 3 quarters · filed 2026-03-06 | |
| 2025-03-31 | $520.00K 10-Q · filed 2025-08-08 | $747.00K derived: sum of 2 quarters · filed 2026-03-06 | ||
| 2024-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | -$218.00K 10-K · filed 2026-03-06 | ||
| 2024-09-30 | -$445.00K 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | -$392.00K 10-Q · filed 2025-08-08 | -$17.00K derived: sum of 2 quarters · filed 2025-08-08 | ||
| 2024-03-31 | $375.00K 10-Q · filed 2025-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |